Joint Pain

Osteoarthritis Pain News

Endo Pharmaceuticals To Acquire Indevus PharmaceuticalsWednesday, January 7, 2009 @ 5:32AMEndo Pharmaceuticals and Indevus Pharmaceuticals, Inc. announced recently that they have entered into a merger agreement under which Endo will commence a tender offer to acquire 100 percent of the outstanding shares of Indevus for approximately $370M, or $4.50 per Indevus share, in cash, and up to an additional approximately $267M, or $3.00 per Indevus share, in cash payable in the future upon ...

Strength training is key to healthTuesday, January 6, 2009 @ 2:06AMMuscle strength peaks in your 20s and then starts to decline. About five to seven pounds of muscle are lost each decade after about age 40 in both men and women.

Endo Pharmaceuticals to Acquire Indevus PharmaceuticalsMonday, January 5, 2009 @ 3:29PM Delivery Technology

Galapagos delivers pre-clinical candidate drug in alliance with GlaxoSmithKline and receives EUR 7.6 million in ...Monday, January 5, 2009 @ 12:08PM Galapagos NV announced today that it has successfully achieved a pre-clinical candidate drug in its osteoarthritis alliance with GlaxoSmithKline (GSK). Galapagos also reached milestones on other compounds in the alliance, triggering payments totaling EUR 7.6 million to Galapagos. To date, Galapagos has earned a total of EUR 25.5 million in payments from GSK under this alliance.

John Simpson’s miracle cureSunday, January 4, 2009 @ 11:33AMWhen John Simpson began exploring the properties of copper on the human body, he never sought fame, just to find an answer to his scientific questions.